Bingyuan Wu
-
- Cardiovascular Function and Risk Factors 7
- Heart Failure Treatment and Management 6
- Cardiovascular Disease and Adiposity 3
- Atrial Fibrillation Management and Outcomes 3
-
- Mesenchymal stem cell research 3
-
- Acute Kidney Injury Research 3
-
- Extracellular vesicles in disease 3
-
- Tissue Engineering and Regenerative Medicine 3
- Co-authors
- Liyuan ZouXiaokun MaDongmei XieShuo LinYanting LuoSuhua LiJieming ZhuYang Chen
In The Last Decade
Bingyuan Wu
28 papers receiving 430 citations
Peers
Comparison fields: 5 of 67
- Cardiology and Cardiovascular Medicine 143
- Genetics 63
- Cancer Research 83
- Nephrology 33
- Molecular Biology 184
Countries citing papers authored by Bingyuan Wu
This map shows the geographic impact of Bingyuan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingyuan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingyuan Wu more than expected).
Fields of papers citing papers by Bingyuan Wu
This network shows the impact of papers produced by Bingyuan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingyuan Wu. The network helps show where Bingyuan Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bingyuan Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 10 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 20 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 14 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 4 | |
| 11 | 2022 | 12 | |
| 12 | 2021 | 1 | |
| 13 | 2021 | 6 | |
| 14 | 2020 | 21 | |
| 15 | 2020 | 47 | |
| 16 | 2020 | 35 | |
| 17 | 2016 | 12 | |
| 18 | 2016 | 30 | |
| 19 | 2015 | 21 | |
| 20 | 2015 | 55 |
About Bingyuan Wu
Bingyuan Wu is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Genetics, having authored 29 papers that have together received 435 indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (7 papers), Heart Failure Treatment and Management (6 papers), Cardiovascular Disease and Adiposity (3 papers), Tissue Engineering and Regenerative Medicine (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), Acute Kidney Injury Research (3 papers), Extracellular vesicles in disease (3 papers) and Mesenchymal stem cell research (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (143 citations), Genetics (63 citations) and Cancer Research (83 citations). Bingyuan Wu has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Liyuan Zou, Xiaokun Ma, Dongmei Xie, Shuo Lin, Yanting Luo, Suhua Li, Jieming Zhu, Yang Chen, Andy Peng Xiang and Ke Yang. Their work appears in journals such as Biomaterials, Oncogene and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.